project id: TCGA-TGCT; case submitter id: TCGA-XE-AAOJ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.98; rna integrity number: 7.2; age at index: 24; days to birth: -9046; ethnicity: hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1985; age at diagnosis: 9046; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IS; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IS; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1550.0; icd 10 code: C62.90; igcccg stage: Intermediate Prognosis; last known disease status: not reported; morphology: 9085/3; primary diagnosis: Mixed germ cell tumor; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1477; initial weight: 300.0; sample id: d1c07b4a-5767-4f21-bebb-8be13383d0a0; sample submitter id: TCGA-XE-AAOJ-01A; portion id: c9be83a5-67ec-4112-8a88-75dd8da41060; portion submitter id: TCGA-XE-AAOJ-01A-12; slide id: 7fbeda3b-73c2-42fe-aad2-e29f621f7862; slide submitter id: TCGA-XE-AAOJ-01A-01-TSA; percent lymphocyte infiltration: 70.0; percent monocyte infiltration: 10.0; percent necrosis: 5.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; section location: TOP;